SE7801030L - Pentapeptidkompositioner och sett att framstella desamma - Google Patents

Pentapeptidkompositioner och sett att framstella desamma

Info

Publication number
SE7801030L
SE7801030L SE7801030A SE7801030A SE7801030L SE 7801030 L SE7801030 L SE 7801030L SE 7801030 A SE7801030 A SE 7801030A SE 7801030 A SE7801030 A SE 7801030A SE 7801030 L SE7801030 L SE 7801030L
Authority
SE
Sweden
Prior art keywords
pentapeptid
prepare
compositions
way
same
Prior art date
Application number
SE7801030A
Other languages
Unknown language ( )
English (en)
Other versions
SE446867B (sv
Inventor
G Goldstein
D H Schlesinger
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Publication of SE7801030L publication Critical patent/SE7801030L/sv
Publication of SE446867B publication Critical patent/SE446867B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7801030A 1977-11-15 1978-01-27 Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter SE446867B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85177777A 1977-11-15 1977-11-15

Publications (2)

Publication Number Publication Date
SE7801030L true SE7801030L (sv) 1979-05-16
SE446867B SE446867B (sv) 1986-10-13

Family

ID=25311654

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801030A SE446867B (sv) 1977-11-15 1978-01-27 Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter

Country Status (7)

Country Link
JP (2) JPS5476543A (sv)
BE (1) BE864121A (sv)
CA (1) CA1105925A (sv)
CH (1) CH639941A5 (sv)
DE (1) DE2804566C2 (sv)
FR (1) FR2408580A1 (sv)
SE (1) SE446867B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
ZA802170B (en) * 1979-04-12 1981-11-25 Ortho Pharma Corp Peptides having thymopoietin-like activity
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
JPS6118560B2 (sv) 1986-05-13
JPS5476543A (en) 1979-06-19
CH639941A5 (en) 1983-12-15
SE446867B (sv) 1986-10-13
DE2804566C2 (de) 1986-01-16
FR2408580A1 (fr) 1979-06-08
JPH0137399B2 (sv) 1989-08-07
FR2408580B1 (sv) 1983-01-07
JPS6150998A (ja) 1986-03-13
DE2804566A1 (de) 1979-05-17
BE864121A (fr) 1978-08-21
CA1105925A (en) 1981-07-28

Similar Documents

Publication Publication Date Title
SE7611646L (sv) Grundmassa och sett att framstella densamma
SE7610788L (sv) Zeolit nu-1 och sett att framstella densamma
SE7602339L (sv) Kinolonderivat och sett att framstella desamma
SE7803770L (sv) Sett att framstella hartskompositioner
IT1174662B (it) Composizioni anti-coccidiosi
SE7606265L (sv) Panel och sett att framstella densamma
SE7514514L (sv) D-homo-20-ketopregnaner och sett att framstella desamma
SE7808184L (sv) Nya prostaglandin-iŸ2-derivat och sett att framstella desamma
AR219293A1 (es) Composiciones de poliester-poliimida
SE7803004L (sv) Isolerruta och sett att framstella denna
SE7803903L (sv) Nytt overoxiderat fast natriumperborat och sett att framstella detsamma
SE427212B (sv) Kulled och sett att framstella densamma
SE7702455L (sv) 4-androsten-3-oner och sett att framstella desamma
SE7803941L (sv) Antioxiderande kompositioner
SE7810085L (sv) Slipartiklar och sett att framstella desamma
SE7801030L (sv) Pentapeptidkompositioner och sett att framstella desamma
SE7813180L (sv) Nya substituerade tiobutyramider och sett att framstella desamma
SE7807376L (sv) Kompositioner
SE7705443L (sv) Biopsi-instrument och sett att anvenda detsamma
SE7614107L (sv) Depa-steroidestrar och sett att framstella desamma
SE7601932L (sv) Ymppolymerisat och sett att framstella desamma
BE865648A (fr) Compositions anticancereuses
SE7714663L (sv) Benso(b)tiofenderivat och sett att framstella desamma
SE7801031L (sv) Pentapeptider och sett att framstella dessa
SE7805413L (sv) 17beta-hydroxi-4-androsten-3-oner och sett att framstella desamma

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7801030-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7801030-3

Format of ref document f/p: F